Oxford BioMedica inks deal to make AstraZeneca's potential COVID-19 vaccine
Published
Britain's Oxford BioMedica has agreed with AstraZeneca to manufacture the drugmaker's experimental COVID-19 vaccine, the cell therapy company said on Thursday.
Full Article